Advertisement
UK markets open in 57 minutes

  • NIKKEI 225

    40,896.23
    -16.14 (-0.04%)
     

  • HANG SENG

    17,518.22
    -281.39 (-1.58%)
     

  • CRUDE OIL

    82.82
    -0.34 (-0.41%)
     

  • GOLD FUTURES

    2,390.30
    -7.40 (-0.31%)
     

  • DOW

    39,375.87
    +67.87 (+0.17%)
     

  • Bitcoin GBP

    43,319.21
    -1,683.71 (-3.74%)
     

  • CMC Crypto 200

    1,151.02
    -15.09 (-1.30%)
     

  • NASDAQ Composite

    18,352.76
    +164.46 (+0.90%)
     

  • UK FTSE All Share

    4,486.08
    -11.89 (-0.26%)
     
Money:

What the new Labour government means for your money

Now that the dust has settled on the election we can take stock of what a Labour win will mean for your finances

Best Momentum Stocks to Buy for January 10th

Zacks Equity Research
·2-min read

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 10th:

Immunocore Holdings plc IMCR: This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.

Immunocore Holdings PLC Sponsored ADR Price and Consensus

Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR Price and Consensus

Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote

Immunocore’s shares gained 52% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score  of A.

Immunocore Holdings PLC Sponsored ADR Price

Immunocore Holdings PLC Sponsored ADR Price
Immunocore Holdings PLC Sponsored ADR Price

Immunocore Holdings PLC Sponsored ADR price | Immunocore Holdings PLC Sponsored ADR Quote

ADVERTISEMENT

Catalyst Pharmaceuticals, Inc. CPRX: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.7% over the last 60 days.

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote

Catalyst’s shares gained 17.4% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.

Catalyst Pharmaceuticals, Inc. Price

Catalyst Pharmaceuticals, Inc. Price
Catalyst Pharmaceuticals, Inc. Price

Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote

AmpriusTechnologies, Inc. AMPX: This ultra-high energy density lithium-ion batteries company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.

Amprius Technologies, Inc. Price and Consensus

Amprius Technologies, Inc. Price and Consensus
Amprius Technologies, Inc. Price and Consensus

Amprius Technologies, Inc. price-consensus-chart | Amprius Technologies, Inc. Quote

Amprius’s shares gained 11.5% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.

Amprius Technologies, Inc. Price

Amprius Technologies, Inc. Price
Amprius Technologies, Inc. Price

Amprius Technologies, Inc. price | Amprius Technologies, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Catalyst Pharmaceuticals, Inc. (CPRX) : Free Stock Analysis Report

Immunocore Holdings PLC Sponsored ADR (IMCR) : Free Stock Analysis Report

Amprius Technologies, Inc. (AMPX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research